Krantz Family Center for Cancer Research Awards

The goal of the Krantz Family Center for Cancer Research Awards is to support Krantz Center faculty in developing highly impactful cancer research projects. The Krantz Awards are expected to drive discovery, bolster cancer research across the institution, and produce a fundamental change in the understanding and treatment of cancer for patients around the world.

The Krantz Awards recognize varying degrees of progress and encourage collaboration across platforms. The number of awards within each category will be determined based on the quality, impact, and promise of individual projects.

Krantz Awards

Quantum Awards - Major initiative poised to have definitive impact on fundamental cancer research, diagnostics, or therapeutics.
Quantum Awards may provide up to $1 million per year for two years, with the possibility to extend to a third year upon review of progress. These awards fund projects that have established proof-of-principle based on promising initial findings, are appropriate for rapid expansion, and have the potential to transform our understanding and treatment of cancer.

Breakthrough Awards - Transformative project based on research findings poised for expansion and scale.
Breakthrough Awards may provide up to $500,000 per year for two years. These awards support new and innovative ideas to the point of proof-of-principle based on promising initial findings.

Spark Awards - Exploratory research with potential to yield major initiative.
Spark Awards may provide up to $100,000 per year for one year to test exciting new thought-provoking ideas to the point of proof-of-principle.

Krantz Awards Announcement Status

The Krantz Family Center for Cancer Research will issue a Request for Applications among its faculty annually. The amount of funding distributed at each cycle will be at the discretion of the Internal and External Review Committees, reflecting the quality of applications. The Internal Review Committee is comprised of senior leaders in the Krantz Family Center for Cancer Research with representation from clinical investigators in the Mass General Cancer Center. The funded projects will be presented annually to the Krantz Family Center for Cancer Research Scientific External Advisory Board.

The proposal submission period for the 2024 Krantz Awards is now closed. The Internal and External Review Committees thoughtfully evaluated the submissions and are thrilled the awardees have launched their research projects. The 2025 Krantz Awards will solicit new applications in the spring.

Meet the 2024 Krantz Award Recipients

Meet the 2023 Krantz Award Recipients

Review Committee Members

View review committee members

• Dafna Bar-Sagi, PhD
  Saul J. Farber Professor in the Department of Biochemistry and Molecular Pharmacology
  Senior Vice President and Vice Dean for Science
  NYU Langone Health
• Nicholas Dyson, PhD
  Professor of Medicine, Harvard Medical School
• David E. Fisher, MD, PhD
  Chair, Department of Dermatology, Massachusetts General Hospital
  Director, Melanoma Program MGH Cancer Center
  Director, Cutaneous Biology Research Center, MGH
  Edward Wigglesworth Professor of Dermatology, Harvard Medical School
• Keith Flaherty, MD
  Director of Clinical Research, Mass General Cancer Center
  Professor of Medicine, Harvard Medical School
• Daniel Haber, MD, PhD
  Director, Krantz Family Center for Cancer Research
  Director, Mass General Cancer Center
  Kurt J. Isselbacher Professor of Oncology (Medicine)
  Investigator, Howard Hughes Medical Institute
• Nir Hacohen, PhD
  Director, Center for Cancer Immunology, Krantz Family Center for Cancer Research
  Director, Center for Cell Circuits, Broad Institute of Harvard and MIT
  David P. Ryan Endowed Chair in Cancer Research
  Professor of Medicine, Harvard Medical School
• Rebecca Heist, MD, MPH
  Associate Director for Clinical Research, Mass General Cancer Center
  Lee Albright and Nile Albright, MD Endowed Chair in Clinical Cancer Research
  Associate Professor of Medicine, Harvard Medical School
• Robert E. Kingston, PhD
  Chief Academic Officer, Massachusetts General Hospital
  Professor of Genetics, Harvard Medical School
• David N. Louis, MD
  Associate Chief of Pathology for Research, Massachusetts General Hospital
  Professor of Pathology, Harvard Medical School
  Atul K. Bhan, MBBS, MD, Endowed Chair in Experimental Pathology
• Andrea McClatchey, PhD
  Director for Academic Affairs, Krantz Family Center for Cancer Research
  Poitras Family Endowed Chair in Cancer Research
  Professor of Pathology, Harvard Medical School
• Raul Mostoslavsky, PhD
  Scientific Director, Krantz Family Center for Cancer Research
  Laurel Schwartz Professor of Oncology (Medicine)
  Professor of Medicine, Harvard Medical School
• David Ryan, MD
  Clinical Director, Mass General Cancer Center
  Chief of Hematology-Oncology, Mass General Cancer Center
  Professor of Medicine, Harvard Medical School
• Arlene Sharpe, MD, PhD
  Chair, Department of Immunology
  Kolokotrones University Professor, Harvard Medical School
• M. Celeste Simon, PhD
  Scientific Director, Abramson Family Cancer Research Institute
  Arthur H. Rubenstein, MBBCh Professor, Department of Cell and Developmental Biology
  University of Pennsylvania Perelman School of Medicine
• Matt Vander Heiden, PhD
  Director, Koch Institute for Integrative Cancer Research
  Lester Wolfe Professor of Molecular Biology, MIT